Significant Vision Recovery from Filler-Induced Complete Blindness with Combined Intra-Arterial Injection of Hyaluronidase and Thrombolytic Agents

2021 ◽  
Author(s):  
Ha H. Nguyen ◽  
Huyen T. T. Tran ◽  
Quan H. Duong ◽  
Minh D. Nguyen ◽  
Hai X. Dao ◽  
...  
Keyword(s):  
Thrombolytic Agents

Thrombolytic Agents

2000 ◽  
Vol 4 (1) ◽  
pp. 75-77 ◽  
Author(s):  
David Green
Keyword(s):  
Thrombolytic Agents

Strategies for the Improvement of Thrombolytic Agents

1991 ◽  
Vol 66 (01) ◽  
pp. 088-110 ◽  
Author(s):  
H R Lijnen ◽  
D Collen
Keyword(s):  
Thrombolytic Agents

Assay Methods and Standard Preparations for Plasmin, Plasminogen and Urokinase in Purified Systems, 1967-1968

1969 ◽  
Vol 21 (02) ◽  
pp. 259-272 ◽  
Author(s):  
A. J Johnson ◽  
D. L Kline ◽  
Norma Alkjaersig
Keyword(s):  
Heart Institute ◽  
Thrombolytic Agents ◽  
National Heart ◽  
Assay Methods

SummaryTo facilitate communication between investigators, the Committee on Thrombolytic Agents of the National Heart Institute suggests standardized reagents and assay methods for the measurement of standard preparations of plasmin, plasminogen, and urokinase with use of casein, fibrin and synthetic esters as substrates.

Acyl-Enzymes as Thrombolytic Agents in a Rabbit Model of Venous Thrombosis

1982 ◽  
Vol 47 (03) ◽  
pp. 269-274 ◽  
Author(s):  
R A G Smith ◽  
R J Dupe ◽  
P D English ◽  
J Green
Keyword(s):  
Venous Thrombosis ◽  
Active Site ◽  
Fibrinolytic Activity ◽  
Rabbit Model ◽  
Fibrinolytic Agent ◽  
Essential Nature ◽  
Thrombolytic Agents

SummaryA derivative of human lys-plasmin in which the active site has been reversibly acylated (BRL 26920; p-anisoyl human lys-plasmin) has been examined as a fibrinolytic agent in a previously described rabbit model of venous thrombosis and shown to be significantly more active and less fibrinogenolytic than free plasmin. A p-anisoylated derivative of a streptokinase (SK)-activated plasmin preparation was significantly less fibrinogenolytic in vivo than the non-acylated enzyme. Acylation increased the fibrinolytic activity of preparations of SK-plasmin activator complexes. BRL 26921, the active site anisoylated derivative of the primary 2-chain SK-plasminogen complex was the most potent fibrinolytic agent studied. SK-Val442-plasminogen complexes, free or acylated, were biologically inactive in this model and confirm the essential nature of fibrin binding processes for effective thrombolysis in vivo.

Comparative efficacy of various thrombolytic agents in treatment of pulmonary embolism

2019 ◽  
Vol 25 (3) ◽  
pp. 23
Author(s):  
N. G. Khorev ◽  
A. V. Beller ◽  
E. V. Borovikov ◽  
V. O. Konkova ◽  
Ya. N. Shoikhet
Keyword(s):  
Pulmonary Embolism ◽  
Comparative Efficacy ◽  
Thrombolytic Agents

Thrombolysis and Thrombolytic Agents

JAMA ◽  
1961 ◽  
Vol 175 (4) ◽  
pp. 284 ◽  
Author(s):  
Kenneth M. Brinkhous
Keyword(s):  
Thrombolytic Agents
Sign in / Sign up

Export Citation Format

Share Document